A new gene therapy, a procurement process gone wrong, and backing away from a biosimilar…

Collaboration seeks to use artificial intelligence to predict how patients will respond to immunotherapy.

A nanofluidic device, smaller than a grain of rice, aims to deliver localized immunotherapy without side effects.

Genetically engineered skin cells expressing highly potent cocaine hydrolase reduce cocaine-seeking behavior in mice.

Only 50 percent of clinical trial results in Europe are reported, but big pharma shares far less than half the blame.

A new automated chemical synthesis machine aims to remove some of the repetitive processes from a scientist’s day.

The FDA’s Janet Woodcock explains how manufacturing will change in the coming years.

Recognizing and celebrating the efforts of both male and female scientists.

What are the hottest trends and techniques in drug development?

Sitting Down With… Kal Patel, MD, Senior Vice President of Digital Health for Flex.